Gene Polymorphism of Matrix Metalloproteinase-12 and-13 and Association with Colorectal Cancer in Swedish Patients

被引:1
作者
Song Van Nguyen [1 ]
Skarstedt, Marita [2 ]
Lofgren, Sture [2 ]
Zar, Niklas [3 ]
Andersson, Roland E. [3 ]
Lindh, Mikael [3 ]
Matussek, Andreas [4 ]
Dimberg, Jan [5 ]
机构
[1] Da Nang Univ Med Technol & Pharm, Dept Lab Med, Da Nang, Vietnam
[2] Ryhov Cty Hosp, Dept Clin Microbiol, Jonkoping, Sweden
[3] Ryhov Cty Hosp, Dept Surg, Jonkoping, Sweden
[4] Ryhov Cty Hosp, Dept Lab Med, Jonkoping, Sweden
[5] Univ Coll Hlth Sci, Dept Nat Sci & Biomed, Jonkoping, Sweden
关键词
MMP12; MMP13; SNP; colorectal cancer; EXPRESSION; PROMOTER; HAPLOTYPES; PROGNOSIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It has been widely reported that matrix metalloproteinases (MMPs) have fundamental roles in pathological processes in cancer through degradation of basal membranes and extracellular matrix. For MMP12 and MMP13, a functional single nucleotide polymorphism (SNP) has been detected -82A -> G (rs2276109) and -77A -> G (rs2252070), respectively. These SNPs are suggested to have an influence on different diseases. The present study evaluated the association between these SNPs in patients with colorectal cancer (CRC) patients and healthy controls. Patients and Methods: Using the TaqMan system, these SNPs were screened in 385 patients with CRC and 619 controls. Results: No significant difference in genotype distribution or in allelic frequencies was found between the two groups. However, we showed that the AA MMP-12 genotype is connected with a higher risk of disseminated CRC (Odds Ratio=1.77; 95% Confidence Interval=1.11-2.81, p=0.018). Conclusion: The results of this study suggest that the -82A -> G (rs2276109) polymorphism of the MMP12 gene reflects clinical outcome of patients with CRC.
引用
收藏
页码:3247 / 3250
页数:4
相关论文
共 23 条
[1]   Molecular pathways in colorectal cancer [J].
Al-Sohaily, Sam ;
Biankin, Andrew ;
Leong, Rupert ;
Kohonen-Corish, Maija ;
Warusavitarne, Janindra .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) :1423-1431
[2]   Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma [J].
Asano, Toshimichi ;
Tada, Mitsuhiro ;
Cheng, Shaoqiang ;
Takemoto, Norihiro ;
Kuramae, Taro ;
Abe, Motoki ;
Takahashi, Osamu ;
Miyamoto, Masaki ;
Hamada, Jun-Ichi ;
Moriuchi, Tetsuya ;
Kondo, Satoshi .
JOURNAL OF SURGICAL RESEARCH, 2008, 146 (01) :32-42
[3]   AP-1 and colorectal cancer [J].
Ashida R. ;
Tominaga K. ;
Sasaki E. ;
Watanabe T. ;
Fujiwara Y. ;
Oshitani N. ;
Higuchi K. ;
Mitsuyama S. ;
Iwao H. ;
Arakawa T. .
InflammoPharmacology, 2005, 13 (1-3) :113-125
[4]   Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression [J].
Borghese, Bruno ;
Chiche, Jean-Daniel ;
Vernerey, Dewi ;
Chenot, Claire ;
Mir, Olivier ;
Bijaoui, Gerard ;
Bonaiti-Pellie, Catherine ;
Chapron, Charles .
HUMAN REPRODUCTION, 2008, 23 (05) :1207-1213
[5]   Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck [J].
Chaudhary, Ajay Kumar ;
Singh, Mamta ;
Bharti, Alok C. ;
Asotra, Kamlesh ;
Sundaram, Shanthy ;
Mehrotra, Ravi .
JOURNAL OF BIOMEDICAL SCIENCE, 2010, 17
[6]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[7]   Matrix metalloproteinases in cancer:: from new functions to improved inhibition strategies [J].
Folgueras, AR ;
Pendás, AM ;
Sánchez, LM ;
López-Otín, C .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2004, 48 (5-6) :411-424
[8]   Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression [J].
Hughes, Simon ;
Agbaje, Olorunsola ;
Bowen, Rebecca L. ;
Holliday, Deborah L. ;
Shaw, Jacqueline A. ;
Duffy, Stephen ;
Jones, J. Louise .
CLINICAL CANCER RESEARCH, 2007, 13 (22) :6673-6680
[9]   Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease [J].
Jormsjö, S ;
Ye, S ;
Moritz, J ;
Walter, DH ;
Dimmeler, S ;
Zeiher, AM ;
Henney, A ;
Hamsten, A ;
Eriksson, P .
CIRCULATION RESEARCH, 2000, 86 (09) :998-1003
[10]   Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world [J].
Kamangar, Farin ;
Dores, Graca M. ;
Anderson, William F. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (14) :2137-2150